APONVIE
Live / Registered — Registered (as of 14 Nov 2023)
What this means for you
Registered since 14 Nov 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97617077
- Registration number
- 7217342
- Mark type
- Word mark
- Filed
- 03 Oct 2022
- Published for opposition
- 29 Aug 2023
- Registered
- 14 Nov 2023
- Attorney of record
- Beth M. Goldman
Goods and services
- Class 005 — Pharmaceuticals: Anti-emetic pharmaceutical preparations; pharmaceutical preparations for the management of nausea and vomiting; pharmaceutical preparations for the management of post-operative nausea and vomiting; pharmaceutical preparations for the management of side effects of surgery; pharmaceutical preparations associated with surgery; nausea treatment preparations; pharmaceutical preparations for the management of chemotherapy induced nausea and vomiting; pharmaceutical preparations for the management of cancer treatment side effects; pharmaceutical preparations for human and animal use for the treatment of pain, for gastrointestinal conditions, cancer, post-operative, chemotherapy-induced nausea and vomiting, autoimmune diseases, infectious diseases, inflammatory diseases, genetic diseases, cardiovascular diseases, orthopedic conditions, and for immunotherapy
Owner
- Heron Therapeutics, Inc., San Diego, CA, US
- Heron Therapeutics, Inc., San Diego, CA, US
- Heron Therapeutics, Inc., San Diego, CA, US
Prosecution history
- 14 Nov 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 14 Nov 2023 — REGISTERED-PRINCIPAL REGISTER
- 29 Aug 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 29 Aug 2023 — PUBLISHED FOR OPPOSITION
- 09 Aug 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 23 Jul 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 19 Jul 2023 — NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
- 18 Jul 2023 — USE AMENDMENT ACCEPTED
- 18 Jul 2023 — ASSIGNED TO EXAMINER
- 09 Mar 2023 — AMENDMENT TO USE PROCESSING COMPLETE
- 09 Mar 2023 — USE AMENDMENT FILED
- 08 Mar 2023 — TEAS AMENDMENT OF USE RECEIVED
- 19 Oct 2022 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 06 Oct 2022 — NEW APPLICATION ENTERED